Tulane Cancer Center Members Janan Jayawickramarajah, PhD, associate dean for research, faculty affairs and PhD programs in the Tulane School of Science and Engineering, and Heather Machado, PhD, associate professor of biochemistry and molecular biology and assistant dean for the biomedical sciences graduate program at the Tulane School of Medicine, will oversee the new Science Policy and Communication Graduate Fellows Program, launching at Tulane this Fall.

An initiative of the Murphy Institute’s Center for Public Policy Research, the graduate-level program is specifically for PhD students entering their second or third year of study, with a goal of giving them the tools they need to be effective scientific communicators and meaningfully engage with policymakers and others who need to know science in order to make better-informed public policy decisions.

Students will also be required to spend two semesters on a project related to community outreach, science policy engagement or science and the economy. The fellowship will culminate with a one-day symposium, where students will present their work to academicians, national leaders and policy makers.

For more information on the Science Policy and Communication Graduate Fellows Program, click here.

All three of this year's Ladies Leukemia League (LLL) research grant recipients are Tulane Cancer Center Members!

Congratulations to Wu-Min Deng, PhD; Zhen Lin, MD, PhD; and Nakhle Saba, MD, who were recently awarded $35,000 LLL grants to help support their leukemia and lymphoma research projects.

Founded in 1969, LLL is a volunteer organization of 225 women dedicated to raising funds for leukemia and lymphoma research in Louisiana, Mississippi and Texas. Since their founding, they have raised over $4.5 million, which they have distributed as "seed" money to research scientists working in leukemia and lymphoma research or related fields.

The LLL issues a call for grant applications each fall and then utilizes a panel of medical advisors to evaluate proposals and make recommendations for funding. They cap awards at $35,000 per investigator in order to provide support for as many worthy projects as possible.

Drs. Deng, Lin and Saba were recognized and awarded with the first half of their grants at the organization's recent grant recipient luncheon. The balance of their awards will be distributed at the halfway point in the grant period, during the organization's annual Fête de Noël fundraiser, scheduled for Monday, December 2, 2024.

LSU / LCMC Health Cancer Center

Faculty Candidate Seminar

Chenran Wang, MD, PhD

Assistant Professor

Department of Cancer Biology

University of Cincinnati College of Medicine

Autophagy in Tuberous Sclerosis Complex and Breast Cancer Brain Metastasis

TODAY - Noon - 1:00 PM

Louisiana Cancer Research Center

1st Floor Auditorium

1700 Tulane Ave., New Orleans

Lunch Available at 11:45 AM

Zoom Meeting ID: 993 1124 6428

Passcode: 437834

Limited Competition Opportunity - High Impact Specialized Innovation Programs in Clinical and Translational Science

Tulane University is a member institution in the Center for Clinical and Translational Science through our partner institution, the University of Alabama at Birmingham. As a member of this network, we are eligible to compete for limited competition awards which a) correspond with the goals of the center, and b) offer a much greater chance of success than a typical extramural opportunity by virtue of the limited field of eligible applicants.

One such FOA is soliciting applications for “High Impact Specialized Innovation Programs in Clinical and Translational Science.” The purpose of this program is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science.

Eligible programs might focus on digital health, decentralized clinical trials, pragmatic trials, artificial intelligence/machine learning algorithms, point-of-care clinical decision support systems, data science and statistical methods, real-world data and real-world evidence, innovative clinical trial designs, genetics and genomics, though this list is non-exhaustive.

Please Note: The CCTS can only submit two applications per grant cycle. They are already at their proposal submission quota for the September 13, 2024, deadline, and they are nearing their quota for the January 13, 2025, cycle.

Interested investigators are urged to contact Tulane University School of Medicine's Director of Clinical Research Programs Andy Barton via email at abarton1@tulane.edu or phone at 504-988-9038 as soon as possible for assistance in gathering resources to support proposal development and submission.

Approaching Deadlines for Department of Defense Award Mechanisms

Lung Cancer Research Program

Patient-Centered Outcomes and Survivorship Award

o  Pre-application submission deadline is July 17, 2024 - 4:00 p.m. Central Time

o  Full application submission deadline is August 7, 2024 - 10:59 p.m. Central Time

American Cancer Society Webinar

Charting a Course: Patient Navigation for Health Equity

Thursday, July 18 - 7:00 - 8:30 PM CDT

Join the American Cancer Society for this policy forum webinar focusing on patient navigation to address health-related social needs and reduce health disparities for cancer patients. While patient navigation is a widely recognized intervention in addressing cancer disparities, funding of and equitable access to navigation services has been a challenge. The forum will highlight how practitioners, healthcare systems, policy makers, and the private sector are addressing these challenges, and how public policies and health systems can ensure that patient navigation is accessible and sustainable for all communities. 

Learn more and REGISTER HERE.

The 19th Annual New Orleans Summer Cancer Meeting -- Empowering Oncology Professionals by Enhancing Cancer Care Through Innovation and Knowledge - will take place July 19-21 at The Roosevelt Hotel in New Orleans, 130 Roosevelt Way.

The meeting agenda includes sessions on the following topics:

• Pharmacology, Cancer Genetics & Neuro Oncology
• Genitourinary Cancers
• Disparity in Cancer
• Gastrointestinal Cancers
• Immunotherapy
• Sarcoma / Thyroid-Thymoma / Survivorship / AI Medicine
• Breast Cancer
• Thoracic Oncology
• Hematology

Tulane Cancer Center Members Chancellor Donald, MD; Nakhle Saba, MD, and Cindy Leissinger, MD, will all be chairing sessions - Dr. Donald on Disparity in Cancer, and Drs. Saba and Leissinger on Hematology. Additionally, Dr. Saba will be presenting Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy, and Dr. Leissinger will be presenting Acquired Inhibitors in Cancer: State of the Art Management. For a full list of distinguished faculty speakers and session chairs, please click here.

All healthcare professionals (HCPs) - physicians, nurses, pharmacists and physician assistants - as well as interested residents, fellows, postdocs and medical student trainees are encouraged to attend.

Residents, fellows and other trainees can register for just $25 and will receive a $25 gift card upon entrance to the meeting. HCPs who are members of the Louisiana Oncology Society can use discount code NOSCM50 to receive a 50% discount on registration. To register, click here.

Cancer Crusaders Seersucker & Sass Summer Gala

Saturday, July 20 - 7:00 - 11:00 PM

Chateau Estates Country Club

3600 Chateau Blvd., Kenner, LA

Grab your best summer seersucker, dust off those dancing kicks and get ready to quick step for a cure at the Cancer Crusaders Seersucker & Sass Summer Gala – Saturday, July 20, 7:00 – 11:00 PM at Chateau Estates Country Club in Kenner, LA. 

Guests will enjoy a sumptuous dinner and groove with a purpose to the energetic and exceptional beats of The Top Cats, all while supporting cancer research.

Cancer Crusaders is a nonprofit, all-volunteer organization dedicated to supporting cancer research in the Greater New Orleans area. Proceeds from the Summer Gala and several other events and initiatives held throughout the year are distributed annually to Tulane Cancer Center and LSU's Stanley S. Scott Cancer Center to support each institution's cancer research efforts.  

So, let’s dance the night away at Seersucker & Sass. Purchase your tickets here:  

Cancer Crusaders - Seersucker & Sass Summer Gala (bidpal.net)

Office Hours with Samuel Jativa, Office of Intellectual Property Management

Tuesday, July 23 -

9:30 AM - 11:30 AM

Tulane School of Medicine Hutchinson Building,

Room 1558

During these weekly open sessions, Samuel Jativa will answer your questions and provide guidance on intellectual property and licensing matters related to research endeavors. The sessions are open to all Tulane faculty and researchers.

Email sjativa@tulane.edu to learn more.

Center for Immunity and Musculoskeletal Diseases Research Seminar

Baohong Zhao, PhD

Associate Professor

Weill Cornell Medical College

Director, Laboratory of Pathological Bone Metabolism and Osteoimmunology

Hospital for Special Surgery

Gas or Brake: How Inflammatory Bone Resorption is Regulated

Tuesday, July 23, Noon - 1:00 PM

Zoom link: https://tulane.zoom.us/j/95303529531

To register for this workshop, please click here.

Support Fund FY 2024-25 Competitions Now Available

Requests for Proposals (RFPs) for Board of Regents Support Fund FY 2024-25 competitions are now available on the BOR website, http://web.laregents.org.  

The below documents set forth all requirements for submission of proposals.

BOR Opportunities & Deadlines

BOR Notice of Intent & Proposal Submission Dates

Across all programs, the BoRSF seeks projects that, if funded, are likely to have clearly defined, significant benefits for Louisiana higher education and economic development. It is critical that applicants carefully read RFPs in their entirety to understand the types of projects and requirements.

Please note: The RFP requires a documented institutional screening process for Departmental Enhancement Proposals only. Departmental Enhancement Proposals MAY NOT BE SUBMITTED WITHOUT DOCUMENTATION OF INSTITUTIONAL REVIEW AND RANKING. To facilitate the review process, submission of a pre-proposal is required, to include this document, along with a CV/Biosketch. The required documents must be emailed as one pdf to Sponsored Projects Administration at dlovrov@tulane.edu no later than September 5, 2024.

2024-2025 Short Experiences in Clinical Trials Funding Opportunity

The Louisiana Clinical and Translational Science (LA CaTS) Center is seeking applications to support training opportunities for junior investigators in clinical and translational research.

Short Experiences in Clinical Trials Awards will be targeted to New Investigators or Early-Stage Investigators (as defined by the NIH - https://grants.nih.gov/policy/early-stage/index.htm) in any discipline who can demonstrate a path towards clinical or translational research. Applicants must hold a PhD, MD, or equivalent degree. Eligible Clinical Trial Scholar Candidates can be faculty or a LA CaTS Roadmap Scholar at any of the LA CaTS Center Member Institutions, with interest in health-related research, but lack sufficient training, experience, or guidance in clinical trials to compete successfully for NIH funding as an independent investigator.

The overall objective of the program is to provide support so that junior faculty can extend and enhance their skill set related to clinical trials by learning the complexities of proposing, obtaining approval, and implementing a novel investigator-initiated trial. Awards can used to visit an experienced clinical trial mentor and their collaborating biostatistical and data management coordinating centers at their respective institutions or to attend specific short-term training programs in clinical research.

Each award may be up to $5,000 in total costs.

Full Application Deadline: This annual RFA has an open application period through June 30, 2025, or until the maximum number of awards allowable are issued for this current fiscal year, whichever comes first. This is a competitive application process. Awards will be based on merit and on a first come, first served basis. We encourage you to apply early in each fiscal year (July 1 – June 30).

Detailed application instructions can be found HERE.

See flyer for all available LA CaTS funding opportunities. 

Questions? Contact info@LACaTS.org

CDMRP / FY24 Kidney Cancer Research Program

SYNOPSIS OF FY24 KCRP AWARD MECHANISMS

CDMRP / FY24 Prostate Cancer Research Program

SYNOPSIS OF FY24 PCRP AWARD MECHANISMS

CDMRP / FY24 Melanoma Research Program

SYNOPSIS OF FY24 MRP AWARD MECHANISMS

CDMRP / FY24 Pancreatic Cancer Research Program

SYNOPSIS OF FY24 PCARP AWARD MECHANISMS

CDMRP / FY24 Rare Cancers Research Program

SYNOPSIS OF FY24 RCRP AWARD MECHANISMS

CDMRP / FY24 Breast Cancer Research Program

SYNOPSIS OF FY24 BCRP AWARD MECHANISMS

CDMRP / FY24 Lung Cancer Research Program

SYNOPSIS OF FY24 LCRP AWARD MECHANISMS

CDMRP / FY24 Ovarian Cancer Research Program

SYNOPSIS OF FY24 OCRP AWARD MECHANISMS

CDMRP / FY24 Peer-Reviewed Medical Research Program

SYNOPSIS OF FY24 PRMRP AWARD MECHANISMS

DELTA INNOVATOR SEARCH SEEKING NEW IDEAS TO IMPROVE HEALTH, ECONOMY IN REGION

Researchers, students, entrepreneurs, and innovators with ideas for advancing the health and economy of the Delta region of Arkansas, Mississippi, and Louisiana are encouraged to enter the inaugural Delta Innovator Search.

The Rural Innovation Alliance, a multi-state initiative committed to transforming the Delta region through technology-based economic development, will accept applications for the search through July 30 at ruralinnovationalliance.org. 

The Innovator Search, part of a planning process launched in May 2023 and funded by the National Science Foundation’s Regional Innovation Engines program, will identify new solutions that have the potential to advance the region’s economy and contribute to better health outcomes for Delta residents. Solutions could include new goods or products, scientific or technical innovations, services, business models, financial strategies or other projects that help build the necessary infrastructure for resilient economic growth in the Delta.

Projects should align with at least one of three target categories:

Scientific or Technical Innovations — New approaches that address the Delta’s unique needs and opportunities, ranging from non-traditional rural health delivery to agricultural innovations such as specialty crop developments or resilient farming practices.

Economic or Financial Innovations — New business models or financial strategies designed to strengthen the region’s economic base by engaging and empowering Delta residents and communities.

Community Impact 2040 — Strategies thoroughly grounded within and committed to making a long-term, positive impact on local Delta communities, including advancements in economic resiliency and improvements in rural health outcomes.

Applicant Eligibility

Individuals, nonprofits, small businesses, entrepreneurs, students, faculty, cooperatives, teams, or other groups and entities with new ideas or solutions that could make the Delta a healthier, economically thriving region are encouraged to apply.

Applicants must be at least 18 years old and residents of Arkansas, Mississippi, or Louisiana OR demonstrate authentic partnership with an organization from the area that serves residents.

Damon Runyon Fellowship Award

The Damon Runyon Cancer Research Foundation is a leading nonprofit organization that funds brave and bold cancer researchers. Damon Runyon’s mission is to identify and support the best early career scientists pursuing innovative research that has the potential to transform cancer prevention, diagnosis, and treatment. Their goal is to encourage new generations of outstanding researchers to pursue paradigm-shifting ideas and approaches as they begin highly productive, successful research careers.

Damon Runyon views cancer research very broadly, including the full spectrum of basic questions important to normal human biology and carcinogenesis, as well as development of new platforms and technologies. They encourage all theoretical and experimental research that has the potential to provide insights into cancer and the search for cancer causes, mechanisms, therapies, and prevention for all types of cancer. 

They are now accepting applications for the prestigious Damon Runyon Fellowship Award.

APPLICATION DEADLINE: August 15, 2024

The primary criteria used to evaluate applicants are:

• the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques, and clarity of presentation),

• the qualifications, experience, and productivity of both the candidate and the Sponsor,

• the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate's ability to independently conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand their scientific skill set. Direct extensions of the candidate's graduate work (in approach, technique, or exact area of study) will not be funded.

Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. 

This four-year award provides $70,000, $72,000, $74,000, and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year. The award may not be used for institutional overhead or indirect costs.

To learn more about the Foundation and the Fellowship Award review process, view the virtual Fellowship Informational Session here. 



Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award

The Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis, or treatment of one or more pediatric cancers. 

Applicants are not required to be pediatricians or members of pediatric departments; however, the proposed research must have direct relevance to one or more pediatric cancers.

Application Guidelines

APPLICATION DEADLINE: August 15, 2024

The primary criteria used to evaluate applicants are:

• potential impact of the research on pediatric cancer
• the quality of the research proposal (importance of the problem, originality of approach, appropriateness of techniques, and clarity of presentation)
• the qualifications, experience, and productivity of both the candidate and the sponsor
• the quality of the research training environment in which the proposed research is to be conducted and its potential for broadening and strengthening the candidate's ability to independently conduct innovative and substantive research. The proposed research and training environment should represent a new opportunity for the candidate to expand their scientific skill set. Direct extensions of the candidate's graduate work (in approach, technique, or exact area of study) will not be funded.

Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. 

This four-year award provides $70,000, $72,000, $74,000, and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. Damon Runyon also provides a Dependent Child Allowance of $1,000 per child per year. The award may not be used for institutional overhead or indirect costs. 

Pfizer Global Medical Grants Announces a New Education RFP in Cervical Cancer

Improving Care for Patients with Recurrent / Metastatic (R/M) Cervical Cancer

The goal of this RFP is to support education for medical oncologists, gynecologic oncologists, pharmacists, eye care providers, nurse practitioners and physician assistants working in the oncology setting caring for patients with r/m cervical cancer relating to treatments, management of adverse events, and long-term outcomes.

To review the full RFP please click here.

Application Due Date: August 22, 2024

Tony Enterante, Senior Development Officer for Corporate, Foundation and Research Relations, is happy to work with applicants on their submissions. You can contact Tony at aenteranteiii@tulane.edu.

Robert L. Fine Cancer Research Foundation Pancreatic Cancer Research Grant

Application Deadline: August 31, 2024

The Robert L. Fine Cancer Research Foundation distributes two awards every other year to outstanding young scientists dedicated to basic and translational pancreatic cancer research. The grant is intended to support research projects that can be carried out in a short period of time with limited resources. The topic of the requested grant applications will be for innovative translational pancreatic cancer research that focuses on bench to bedside advances. The grant mechanism supports different types of basic and translational projects, including pilot and feasibility studies, self-contained research projects, development of new research methodology and development of new research technology. This grant does not support solely clinical research.

The grant amount will be $250,000 to cover direct costs only. The length of the grant will be for two years payable in yearly installments. Pre-award costs are allowable, up to 30 days prior to the grant initiation date; however, the incurrence of pre-award costs imposes no obligation on the foundation to grant the award. Funding for awardees will start January 1, 2025.

For more information, click here.

Request for Proposals

Equity in Access Research Program

The Leukemia & Lymphoma Society (LLS) has just released a Request for Proposals (RFP) for its Equity in Access Research Program, which is dedicated to funding health services research.

They are reissuing the RFP Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups. Awards will be a maximum of $2.5 million each, over 5 years.

Specifically, they seek proposals that will implement and evaluate interventions designed to:

• Mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups
• Quantitatively measure the impact of these interventions on patient accrual

They are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.

It is not necessary for applicants to have previously conducted research in blood cancer. The due date for Letters of Intent is September 12, 2024 at 2 pm CST. 

For more information, visit LLS.org/EquityinAccess

2025 Macy Faculty Scholars Program

Call for Applications

Application Deadline: September 15

The 2025 Macy Faculty Scholars Program aims to identify and nurture promising early-career educators in medicine and nursing. Macy Faculty Scholars receive up to $250,000 of salary, project, and professional development support over two years to implement an educational project in their home institutions.

Visit the website to learn more about the program and get started on your application. 

Acknowledging Tulane Cancer Center Support in Publications

One of the responsibilities of membership in the Tulane Cancer Center is acknowledgement of Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in presentations and publications

We suggest using the following wording when acknowledging Tulane Cancer Center support: "This work was supported by the Tulane Cancer Center, part of Tulane Medical School and a consortium partner of the Louisiana Cancer Research Center."

Framework for NIH Reform Unveiled,

Stakeholder Input Requested

House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) recently unveiled a framework that lays out the current challenges facing the National Institutes of Health (NIH) and contains recommendations for reform.

The framework covers the following areas:

• Mission and Leadership Reform: NIH Mission and Leadership Must Be Accountable, Integrated, and Agile
• Funding Reform: NIH Funding Mechanisms Must Be Clear, Responsible, and Reflective of Congressional Intent
• Grant Reform: NIH Grant Research Must Protect Against National Security Risks and Threats, and be Independent, Innovative, Responsive, and Transparent

CLICK HERE to view the full framework.

Stakeholders wishing to submit any feedback on the framework or provide additional thoughts, ideas, or suggestions for reform can do so by emailing NIHReform@mail.house.gov by August 16, 2024.

Unlimited Access to GIDEON

The Matas Library is now providing unlimited access to GIDEON, the Global Infectious Disease and Epidemiology Network. Whether you're a researcher, faculty, or a medical student, GIDEON serves as your comprehensive hub for infectious disease data, research, and diagnostics.

With GIDEON, you can:

1. Access a vast repository of information on diseases, vaccines, and microbes.

2. Use a sophisticated probability engine and interactive decision tree to identify pathogens.

3. Construct step-by-step diagnoses tailored to your specific case.

4. Visualize data through dynamic charts and maps for enhanced understanding and analysis.



Visit GIDEON here.

Product Updates and Open Training Sessions from Elsevier

Explore the latest product updates and join open training sessions from Elsevier, featuring Complete Anatomy and Osmosis. Open webinar sessions are available all summer!

Learn more and register here.

Open Access Publishing Opportunities

Tulane University Libraries has negotiated agreements with publishers like Springer Nature, Elsevier, Oxford University Press, and Wiley to waive article processing charges (APCs) for Tulane contributing authors.

To learn more about these waivers and any associated restrictions, click here.

Please visit Tulane Cancer Center on Facebook, Instagram and LinkedIn and follow us for all the latest news in cancer research, education and patient care.

You can access our profile pages by clicking on the icons below.

Tulane Cancer Center Branded Assets

Tulane Cancer Center has recently undertaken a brand refresh that not only streamlines and modernizes the look and feel of our brand but also aligns us more closely with the School of Medicine branding.

With that in mind, we have developed a full suite of branded assets for your immediate use, including:

1. A Tulane Cancer Center-branded PowerPoint Slide Master
2. A Tulane Cancer Center-branded Scientific Poster Template (sized at 4 feet x 3 feet)
3. Tulane Cancer Center-branded Zoom Backgrounds
4. Tulane Cancer Center’s updated logo
5. Tulane Cancer Center-branded Email Signature Blocks

All Tulane Cancer Center Members should have received these files via a recent listserv email. If you did not receive the email but would like to begin using these templates, please contact Melanie Cross at mcross@tulane.edu.

Please also continue to acknowledgement your Tulane Cancer Center membership and/or use of shared resources, salary support or other Tulane Cancer Center funding in all presentations and publications.

Thank you for your assistance in helping us to expand our visibility while showcasing the depth and breadth of our outstanding basic, translational and population science research and clinical care.  

Next Generation Sequence Analysis Core

The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.

More Information 

Cell Analysis Core

The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.

More Information

Tulane Cancer Center & LCRC Membership

Any Tulane University faculty member whose research relates to or could potentially relate to cancer – directly or indirectly – should become a member of the Tulane Cancer Center (TCC). As a member, you have access to TCC's funding opportunities, research collaboration events, and shared resources. Please click here for our membership guidelines and our online application form.

Cancer-focused faculty are also encouraged to become members of the Louisiana Cancer Research Center, a partnership between the State's foremost cancer research institutions - Tulane University School of Medicine, LSU Health Sciences Center New Orleans, Xavier University of Louisiana and Ochsner Health. Membership in the LCRC provides access to additional funding opportunities exclusively offered to LCRC members. Please click here for the LCRC's membership guidelines and online application form.

Subscribe to Nexus

If you know someone who is interested in subsribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.

Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.